ELOCLEAR authorized in the EU: what manufacturers and biocide distributors must do

Key data

The biocide ELOCLEAR can now be marketed and used throughout the European Union under a single regulatory framework. The Commission Implementing Regulation (EU) 2026/2028, published on 11 September 2026 and in force from the previous day, grants this authorization under the Regulation (EU) No 528/2012 on the placing on the market and use of biocidal products.

What is relevant for companies in the sector is not just that the product is authorized: it is that from now on it operates under specific binding conditions. Anyone who manufactures, distributes or professionally uses ELOCLEAR must verify that their activity complies exactly with the terms of this authorization, because non-compliance can result in sanctions or withdrawal of market access.

What does this regulation establish?

The regulation grants a Union authorization for the single biocide ELOCLEAR. This type of authorization, provided for in Regulation (EU) No 528/2012, allows a biocidal product to be marketed and used in all Member States without the need to process independent national authorizations in each country.

The key elements established by the regulation are as follows:

• Single European-wide authorization: ELOCLEAR can operate in any Member State under the same regulatory framework, without duplicating national procedures.
• Specific compliance conditions: the authorization holder must respect the conditions established in the regulation, which include labeling, permitted uses and applicable restrictions.
• Obligation to comply for professional users: companies in the disinfection and treatment sector that already use or plan to use ELOCLEAR must verify that their specific use is within the authorized scope.
• Consequences of non-compliance: the regulation expressly provides that non-compliance with the conditions may result in sanctions or withdrawal of authorization.

This authorization simplifies market access for the authorization holder, but does not eliminate compliance obligations: it replaces them with a single set of conditions that must be respected in all countries where operations take place.

Economic and operational impact

Union authorization has two sides for companies in the biocide sector:

Opportunity: the holder of ELOCLEAR authorization eliminates the burden of processing and maintaining national authorizations in each of the Member States where it wishes to operate. This means a direct reduction in administrative costs, processing times and fragmented regulatory risk. For distributors operating in several European countries, this change significantly simplifies compliance management.

Risk: the existence of a single authorization does not mean an absence of obligations. The labeling conditions, permitted uses and restrictions established in the regulation are mandatory throughout the EU. Any deviation—incorrect labeling, unauthorized use or distribution outside the terms—can result in sanctions or withdrawal of authorization, with the resulting commercial impact.

For professional users (disinfection companies, water treatment, industrial hygiene, among others), the operational impact is immediate: they must review their ELOCLEAR usage protocols and confirm that they comply with the authorized terms before continuing to operate with the product.

Who does it affect?

• ELOCLEAR manufacturers: they are the authorization holder and the main parties obliged to comply with all the conditions of the regulation (labeling, uses, restrictions).
• Distributors in the EU: must ensure that the product they market complies with the current authorization and that they do not distribute ELOCLEAR for unauthorized uses.
• Professional users: companies in the disinfection, water treatment, industrial hygiene or any other field where ELOCLEAR is used professionally. They must verify that their specific use is within the authorized scope.
• Regulatory compliance advisors and product managers: need to update their compliance documentation and review internal product usage protocols.

Practical example

A Spanish disinfection services company that uses ELOCLEAR in its regular operations must, as of 10 September 2026, verify that each application of the product is carried out within the uses expressly permitted by Commission Implementing Regulation (EU) 2026/2028.

If this company also operates in France or Portugal, the good news is that it does not need to process additional authorizations in those countries: the Union authorization is directly valid. However, if it uses ELOCLEAR for a use not contemplated in the authorization—even if that use was customary before the regulation came into force—it exposes itself to sanctions and possible withdrawal of access to the product throughout the EU.

The first practical step is to request from the manufacturer or distributor the updated technical sheet with the uses authorized under the new regulation and compare it with the company's internal protocols.

What should companies do now?

1. Verify if you use, manufacture or distribute ELOCLEAR: if your company has any relationship with this product, this regulation affects you directly and you must act immediately.
2. Review authorized uses: request from the authorization holder or your supplier the updated documentation detailing the permitted uses, required labeling and applicable restrictions under Regulation (EU) 2026/2028.
3. Update internal protocols: compare current uses of ELOCLEAR in your company with authorized uses. If you detect deviations, correct them before continuing to operate with the product.
4. Review product labeling: ensure that the labeling of ELOCLEAR in your distribution chain or facilities complies with the specific conditions of the regulation.
5. Document compliance: maintain an updated record of product uses and measures taken to comply with the authorization. This documentation will be key in the event of an inspection.
6. Consult a biocide regulation specialist if you have doubts about whether your specific use is within the authorized scope, especially if you operate in several Member States.

Official source

Consult complete regulation at official source

Disclaimer: This article is for informational purposes only and does not constitute legal advice. For specific decisions, consult a qualified professional. Source: https://eur-lex.europa.eu/./legal-content/AUTO/?uri=OJ:L_202602028